Updates

Latest news, events, resources, and thought pieces from the Exchange's blog

Why Aren’t Female Condom Markets Working?

Gloria dreams of a contraceptive and HIV prevention method that she can control. As a university student in Zambia, Gloria goes on dates in between working and studying. Some of...

DHS Program Seeks Feedback on Model Questionnaires

The Demographic and Health Surveys (DHS) Program is currently soliciting feedback on its model questionnaires, optional modules, and biomarkers. The purpose of collecting user input is to enhance the DHS-8...

NICHD Solicits Feedback on Strategic Plan

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has issued a Request for Information (RFI) to solicit feedback on its new strategic plan. NICHD is seeking input from...

New Female Condom: How to Interest Providers and Retailers

Guest  bloggers are Danielle Harris of WCG Cares and Ashley Jackson of PSI. This post originally appeared on the PSI Impact blog. Clara took a chance and bought 15 units of Whisper,...

Microneedle patches designed to deliver long-acting contraceptive hormone

Sustained hormonal release of a contraceptive hormone may be possible via the use of biodegradable levonorgestrel-releasing microneedle patches, according to a recent paper published in the journal Nature Biomedical Engineering.  This...

FDA plans new office to revamp drug review process

The United States Food and Drug Administration (U.S. FDA) has plans to create the Office of Drug Evaluation Science (ODES) in an effort to improve how new medicines are currently...

More on the blog

Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


Resources

A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Featured Resources

Other key resources related to contraceptive research and development

Calliope, the Contraceptive Pipeline Database, includes information on potential contraceptive targets and leads, products in pre-clinical and clinical development, and a selection of novel and long-acting products with limited market availability.
CAPRI, the Contraceptive Active Pharmaceutical Ingredient Database, lists biological and chemical properties for 27 active pharmaceutical ingredients found in contraceptives, along with data on their pharmacology, toxicology, impurities, metabolites, and use in marketed products.
Contraceptive Drug Interactions is a database that catalogues potential interactions between contraceptive drugs and drugs from other therapeutic classes. Changes in drug pharmacokinetics, effectiveness, and adverse effects are provided.

Contribute

We want you to join the exchange!

The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback

twittermail